CALR and early-onset autosomal dominant Alzheimer disease: Accumulating evidence suggests that a reduced level of CRT is associated with the pathologies of neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS)23,31 and Alzheimer’s disease (AD)22,32.